Literature DB >> 6669221

The effects of vasopressin on positively rewarded responding and on locomotor activity in rats.

J S Andrews, B A Newton, A Sahgal.   

Abstract

It has been suggested that arginine-vasopressin (AVP) enhances cognitive, and especially mnemonic, ability. Most studies have employed shock avoidance paradigms; we report the results of a study in which saline or vasopressin (0, 0.5 or 1 microgram, mcg, per rat, subcutaneous) pre-treated rats learned to press a lever for food reward. AVP was found to have a disruptive effect on aquisition, particularly when the tendency for these rats to produce extreme learning scores was taken into account. Locomotor activity, with and without vasopressin pre-treatment (0, 0.5, 1 or 2 mcg/rat), was also studied. Only the highest dose significantly reduced activity; therefore, the effects of AVP on acquisition are unlikely to have been caused by motor disruption. The results are discussed in terms of an hypothesis which suggests that AVP enhances arousal, hence influencing performance.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6669221     DOI: 10.1016/0143-4179(83)90004-5

Source DB:  PubMed          Journal:  Neuropeptides        ISSN: 0143-4179            Impact factor:   3.286


  5 in total

1.  Desamino-D-arg8-vasopressin (DDAVP), unlike ethanol, has no effect on a boring visual vigilance task in humans.

Authors:  A Sahgal; C Wright; I N Ferrier
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

2.  Locomotor activity and neurotensin: resolution of discrepancies in effects?

Authors:  A Sahgal; A B Keith
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

3.  Opposing effects of vasopressin on matching versus non-matching to position: further evidence for response, not memory, modulation.

Authors:  A Sahgal; A B Keith; S Lloyd
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

4.  Acute prosocial effects of oxytocin and vasopressin when given alone or in combination with 3,4-methylenedioxymethamphetamine in rats: involvement of the V1A receptor.

Authors:  Linnet Ramos; Callum Hicks; Richard Kevin; Alex Caminer; Rajeshwar Narlawar; Michael Kassiou; Iain S McGregor
Journal:  Neuropsychopharmacology       Date:  2013-05-16       Impact factor: 7.853

5.  Body temperature and cardiac changes induced by peripherally administered oxytocin, vasopressin and the non-peptide oxytocin receptor agonist WAY 267,464: a biotelemetry study in rats.

Authors:  C Hicks; L Ramos; T Reekie; G H Misagh; R Narlawar; M Kassiou; I S McGregor
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.